A 48-year-old woman with hypertension and a history of acute coronary syndrome (ACS) 6 months ago presents for antihypertensive optimization. She is already on aspirin and a statin. Which antihypertensive agent is the preferred first-line choice for secondary prevention of recurrent cardiovascular events?